Article Information
History
- September 30, 2021.
Article Versions
- Version 1 (April 27, 2021 - 10:42).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Brian M. Gurbaxani, PhD1,*,#,
- Andrew N. Hill, PhD2,*,#,
- Prabasaj Paul, PhD3,
- Pragati V. Prasad, MPH3 and
- Rachel B. Slayton, PhD3
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA
- 1Office of Science, Deputy Director for Public Health Science and Surveillance, CDC, and Departments of Electrical and Computer Engineering and Industrial and Systems Engineering at the Georgia Institute of Technology
- 2Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, and Department Biostatistics and Bioinformatics Department, Rollins School of Public Health, Emory University
- 3CDC COVID-19 Response Team
- ↵#Address for Correspondence:
Brian M. Gurbaxani, PhD. Address: 1600 Clifton Rd NE, Atlanta, GA 30333. Email: buw8{at}cdc.gov. Andrew N. Hill, PhD. Address: 1600 Clifton Rd NE, Atlanta, GA 30333. Email: fyu7{at}cdc.gov.
↵* These authors contributed equally to this work
Posted September 30, 2021.
Evaluation of Different Types of Face Masks to Limit the Spread of SARS-CoV-2 – A Modeling Study
